MTA is proud to be a SPRING Sector Specific Accelerator Operator

Med Tech Alliance Partners

About Accuron Technologies Limited

Accuron is a technology and precision engineering group wholly-owned by Temasek Holdings. With core competencies in precision manufacturing, material processing and systems design and integration, the Accuron group serves the aerospace, electronics and medical industries. Accuron’s medical technology companies provide therapeutic, diagnostic, and medical device manufacturing solutions to customers around the globe. Dornier MedTech GmbH, known as a pioneer and market leader in the urology market, continues to provide premium therapeutic, diagnostic and service solutions worldwide for numerous healthcare fields. Veredus Laboratories Pte Ltd, specialises in the development, manufacture, and marketing of innovative molecular diagnostic solutions in the clinical, specialty, and custom testing markets based on a proprietary Lab-on-Chip platform. Advanced Materials Technologies Pte Ltd serves the contract manufacturing needs of the medical technology sector through providing materials expertise and high precision engineering capabilities.
About Greatbatch, Inc.

Greatbatch, Inc. founded in 1970, develops and manufactures batteries, engineered components and more for use in medical devices. The company supplies at least one component in 95% of all implanted pulse generators in the world and has manufacturing or research and development facilities in US, Europe, South America and Singapore.

Greatbatch announced in July 2012, the establishment of their Active Implantable Medical Device (AIMD) Research and Development Centre here in Singapore - the first of its kind in the country - as a continuation of Greatbatch's medical device strategy and the first step of its Asia Pacific strategy to engage in emerging healthcare markets. Greatbatch Singapore’s AIMD R&D Centre will focus mainly on the design and development of medical devices for use in the cardiovascular and neuromodulation space in these emerging markets.
About Mr Lu Yoh Chie

Executive Chairman and founder of Biosensors International Group, first biomedical company with global presence listed in Singapore. Prior to founding the Biosensors in 1990, Mr. Lu established Asia-based operations for the Medical Division of Gould Inc., specialised in surgical and critical care catheters and instruments. He held various senior positions with Gould before advancing to the position of President of the Asia-Pacific division. In 1986, Mr. Lu participated in a management-led leveraged buyout of the division from Gould. He continued as President of the Asia-Pacific division through 1988 until it was sold to British Oxygen Corporation. He then served as President of Asia-Pacific with British Oxygen until 1990. He is a member of Singapore Intellectual Property Steering Committee for the Ministry of Law; Chairman of Clearbridge Biomedical, a start-up supported by Spring; and a Board Member of The National Research Foundation. Mr. Lu, with more than 30 years’ experience in the medical industry, is a successful entrepreneur with extensive experience and knowledge on medical technology market opportunities and strategies for commercialisation.